Indication for Use: It is indicated for the embolization of lesions in the peripheral and neurovasculature, including arteriovenous malformations(AVM) and hypervascular tumors.
Models:LAVA-12, LAVA-18, LAVA-34
LavaTM liquid embolic system for AVM is primarily indicated for the treatment of cerebral AVMs to prevent bleeding and reduce the risk of neurological deficits. It is particularly useful for deep-seated AVMs, where surgical resection may cause significant morbidity or even death. In addition, it is a useful adjunct to surgery or radiosurgery to achieve complete obliteration of the AVM nidus.Lava liquid embolic systems is also used for the treatment of peripheral AVMs, hypervascular tumors, and other vascular malformations. One of the key features of this innovative system is the use of non-adhesive materials, which help to prevent the occlusion of healthy blood vessels and ensure that the embolic agent remains in the targeted area. Latest technology of EVOH co-polymer is a major advancement in interventional radiology, providing clinicians with a reliable and effective tool for treating complex vascular malformations. Its high precision, versatility, and safety make it an ideal choice for patients who require embolization therapy for AVMs.
Features &Advantages
1. The Non-adhesive, latest technology of EVOH co-polymer enables physicians to use lower volumes of embolic agents, reducing the risk of complications and making the procedure safer for patients. Furthermore, the innovative system ensures complete occlusion of the targeted vessel while avoiding excessive embolization, making it ideal for treating challenging AVMs.
2. LavaTM liquid embolic system for AVM adapts to different clinical requirements. The different viscosity levels provide the physician with a range of options to select the optimal level for each individual patient's needs. Physicians can select a lower viscosity level when treating smaller AVMs or when a more targeted approach is required. On the other hand, higher viscosity levels are ideal for larger AVMs or where a more effective occlusion is needed.
3. It can penetrate deeper into the distal microvessels, ensuring complete occlusion of the abnormal blood vessels. This enhanced fluidness of the embolic agent also reduces the risk of migration, ensuring that the embolic agent remains in place, blocking blood flow to the AVM.
4. The Lava delivers the embolic agent directly to the site where it is needed, ensuring that there is no leakage or spillover. Additionally, the system provides for a stable and controlled release of the embolic agent which helps to avoid any adverse reactions or complications.
5. One of the primary advantages of this system is its superior visibility. This is due to the highly translucent nature of the Tantalum powder used in its composition. This feature enables healthcare professionals to monitor the progress of the embolization process more accurately, thereby increasing the chances of a successful outcome.
